Evidence map›Paper›PMID 28379384›Full record

ArticleThe Journal of clinical endocrinology and metabolism2017

Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.

Katherine Wesseling-Perry, Riikka E Mäkitie, Ville-Valtteri Välimäki, Tero Laine, Christine M Laine, Matti J Välimäki, Renata C Pereira, Outi Mäkitie

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Bone fragility and osteoporosis in children and young adults.Journal of endocrinological investigation · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Early-Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Review
  12. Early-Onset Osteoporosis.Calcified tissue international · 2022
    Review
  13. Article
  14. Review
  15. Plastin 3 in health and disease: a matter of balance.Cellular and molecular life sciences : CMLS · 2021
    Review
  16. Article
  17. Frontiers in endocrinology · 2020
    Article
  18. Review
  19. Frontiers in endocrinology · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Katherine Wesseling-PerryDepartment of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095.
Riikka E MäkitieFolkhälsan Institute of Genetics, University of Helsinki, 00014 Helsinki, Finland.
Ville-Valtteri VälimäkiDepartment of Orthopedics and Traumatology, Helsinki University Central Hospital and Helsinki University, Jorvi Hospital, 02740 Espoo, Finland.
Tero LaineDepartment of Orthopedics, Institute of Clinical Sciences, Sahlgrenska University Hospital and University of Gothenburg, 41345 Gothenburg, Sweden.
Christine M LaineChildren's Hospital, University of Helsinki and Helsinki University Hospital, 00014 Helsinki, Finland.
Matti J VälimäkiDivision of Endocrinology, Department of Medicine, Helsinki University Central Hospital, 00029 Helsinki, Finland.
Renata C PereiraDepartment of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095.
Outi MäkitieFolkhälsan Institute of Genetics, University of Helsinki, 00014 Helsinki, Finland.
Helsinki University Hospital · FIUniversity of California, Los Angeles · USUniversity of Gothenburg · SEJorvi Hospital · FIUniversity of Helsinki · FI

Funding

FGF-23 Regulation in Chronic Kidney DiseaseK23DK080984 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WESSELING-PERRY, KATHERINE · 2009 to 2013
$872k
Osteoblast and Osteocyte Dysfunction in Chronic Kidney DiseaseR03DK098627 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WESSELING-PERRY, KATHERINE · 2014 to 2015
$154k
NIDDK NIH HHS K23 DK080984NIDDK NIH HHS R03 DK098627
6 · The paper itself

Abstract

Context: Osteocytes express proteins that regulate bone remodeling and mineralization. Objective: To evaluate the relationship between osteocyte-specific protein expression and bone histology in patients with monogenic osteoporosis due to wingless integration site 1 (WNT1) or plastin 3 (PLS3) mutations. Design and Setting: Cross-sectional cohort study at a university hospital. Participants: Six patients (four males; ages: 14 to 72 years) with a heterozygous WNT1 mutation and five patients (four males; ages: 9 to 70 years) with a heterozygous/hemizygous PLS3 mutation. Methods and Main Outcome Measures: Immunohistochemistry was performed for fibroblast growth factor 23 (FGF23), dentin matrix protein 1 (DMP1), sclerostin, and phosphorylated (phospho-)β-catenin in iliac crest samples and compared with bone histomorphometry. Results: FGF23 expression in WNT1 patients was 243% that observed in PLS3 patients (P < 0.01). DMP1, sclerostin, and phospho-β-catenin expression did not differ between groups. Serum phosphate correlated inversely with FGF23 expression (r = -0.79, P = 0.01) and serum ionized calcium correlated inversely with sclerostin expression (r = -0.60, P = 0.05). Phospho-β-catenin expression correlated inversely with DMP1 expression (r = -0.88, P < 0.001), osteoid volume/bone volume (r = -0.68, P = 0.02), and bone formation rate (r = -0.78, P < 0.01). FGF23 expression did not correlate with DMP1 expression, sclerostin expression, or bone histomorphometry. Marrow adiposity was higher in WNT1 than in PLS3 patients (P = 0.04). Conclusions: Mutations that disrupt WNT signaling and osteocytic mechanosensing affect osteocyte protein expression. Abnormal osteocyte function may play a role in the pathogenesis of monogenetic forms of osteoporosis.

Indexed as

AdolescentAdultAgedBiopsy, NeedleBone and BonesBone DensityBone RemodelingCells, CulturedCohort StudiesCross-Sectional StudiesFemaleFibroblast Growth Factor-23Fibroblast Growth FactorsGene Expression RegulationHospitals, UniversityHumansFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth FactorsMembrane GlycoproteinsMicrofilament ProteinsplastinWnt1 ProteinWNT1 protein, human

Identifiers

PMID28379384
PMCPMC5505188
OpenAlexW2604496766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.